心脏-脏-代谢风险概况的年龄分层差异
Mihaela Simona Popoviciu1,2, Timea Claudia Ghitea3
1Department of Preclinical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 1 Decembrie, 410028 Oradea, Romania.
心脏--代谢风险随着年龄的增长而变化,年轻人表现出代谢问题,老年人面临血管和脏问题. 在更年轻,代谢负担较大的个体中,早期发现血管风险是关键.
科学领域:
- 老年学是一门学科.
- 心血管医学 心血管医学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 代谢综合征是代谢综合征的一种.
背景情况:
- 心脏--代谢疾病的易感性随着年龄的增长而增加.
- 风险因素在成年人一生中不断演变,代谢问题在年轻人中占主导地位,老年人群的血管/脏变化.
- 了解与年龄相关的风险重构可以为定制的预防策略提供信息.
研究的目的:
- 为了研究心脏--代谢风险概况的年龄分层差异.
- 在不同成年年龄组中识别主导风险标志物.
- 为风险评估和预防提供生命历程方法的信息.
主要方法:
- 对287名成年人进行的横截面观察研究.
- 参与者分为三个年龄组:<65,65-75,和>75岁.
- 评估人体测量,血压,代谢参数,肝酶,炎症标志物,功能 (eGFR,UACR) 和胰岛素耐药性 (TyG指数).
主要成果:
- 较年轻的成年人 (<65岁) 显示了代谢概况 (更高的BMI,葡萄糖,甘油三,TyG指数).
- 老年人 (>65) 呈现出血管-的表型 (较高的SBP,较低的DBP, eGFR下降).
- 肝酶随着年龄的增长而下降;FIB-4指数增加;UACR和CRP没有显著的年龄差异.
结论:
- 心脏-脏-代谢风险概况呈现出明显的年龄分层模式.
- 代谢风险在年轻人中占主导地位,而血管和脏的脆弱性随着年龄的增长而增加.
- 在年轻人中早期发现血管/微血管风险对于预防晚期和血管衰老至关重要.
更多相关视频
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
相关概念视频
Relative Risk
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Cardiomyopathy IV: Restrictive Cardiomyopathy
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction
